Higher levels of ACE2 expression in patients with comorbidities such as cardiovascular disease, COPD, and in diabetic pancreatic islets increase the susceptibility of contracting SARS-CoV-2 infection and subsequent COVID-19 severity. This evidence concerns the gene ACE2 and cardiovascular disorder.